Hepatitis B virus core protein as a Rab-GAP suppressor driving liver disease progression
Science Bulletin · 2024
DOI: 10.1016/j.scib.2024.04.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Bulletin, 2024. Verfasst von Yu Su und 15 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecuri…. Hauptthemen laut MEDLINE: Mice, Transgenic, rab GTP-Binding Proteins, Hepatitis B virus, Hepatitis B, Chronic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Chronic hepatitis B virus (HBV) infection can lead to advanced liver pathology. Here, we establish a transgenic murine model expressing a basic core promoter (BCP)-mutated HBV genome. Unlike previous studies on the wild-type virus, the BCP-mutated HBV transgenic mice manifest chronic liver injury that culminates in cirrhosis and tumor development with age. Notably, agonistic anti-Fas treatment induces fulminant hepatitis in these mice even at a negligible dose. As the BCP mutant exhibits a striking increase in HBV core protein (HBc) expression, we posit that HBc is actively involved in hepatocellular injury. Accordingly, HBc interferes with Fis1-stimulated mitochondrial recruitment of Tre-2/Bub2/Cdc16 domain family member 15 (TBC1D15). HBc may also inhibit multiple Rab GTPase-activating proteins, including Rab7-specific TBC1D15 and TBC1D5, by binding to their conserved catalytic domain. In cells under mitochondrial stress, HBc thus perturbs mitochondrial dynamics and prevents the recycling of damaged mitochondria. Moreover, sustained HBc expression causes lysosomal consumption via Rab7 hyperactivation, which further hampers late-stage autophagy and substantially increases apoptotic cell death. Finally, we show that adenovirally expressed HBc in a mouse model is directly cytopathic and causes profound liver injury, independent of antigen-specific immune clearance. These findings reveal an unexpected cytopathic role of HBc, making it a pivotal target for HBV-associated liver disease treatment. The BCP-mutated HBV transgenic mice also provide a valuable model for understanding chronic hepatitis B progression and for the assessment of therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China; Shanghai Frontiers Scien…
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
- Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Laboratory of Cellular Immunity, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: gaoyueqiu@shutcm.edu.cn.
- State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, China. Electronic address: klan@whu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
Zitieren
APA
Su, Y., Bu, F., Zhu, Y., Yang, L., Wu, Q., Zheng, Y., Zhao, J., Yu, L., Jiang, N., Wang, Y., Wu, J., Xie, Y., Zhang, X., Gao, Y., Lan, K., & Deng, Q. (2024). Hepatitis B virus core protein as a Rab-GAP suppressor driving liver disease progression. Science Bulletin. https://doi.org/10.1016/j.scib.2024.04.014
Vancouver
Su Y, Bu F, Zhu Y, Yang L, Wu Q, Zheng Y, et al. Hepatitis B virus core protein as a Rab-GAP suppressor driving liver disease progression. Science Bulletin. 2024. doi:10.1016/j.scib.2024.04.014
BibTeX
@article{Su2024,
author = {Su, Yu and Bu, Fan and Zhu, Yuanfei and Yang, Le and Wu, Qiong and Zheng, Yuan and Zhao, Jianjin and Yu, Lin and Jiang, Nan and Wang, Yongxiang and Wu, Jian and Xie, Youhua and Zhang, Xinxin and Gao, Yueqiu and Lan, Ke and Deng, Qiang},
title = {Hepatitis B virus core protein as a Rab-GAP suppressor driving liver disease progression},
journal = {Science Bulletin},
year = {2024},
doi = {10.1016/j.scib.2024.04.014}
}
EUVIMED